You are here

  • Home
  • Archive
  • Volume 2, Issue 6
  • Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial

Article metrics

Article menu
XML
Cardiovascular medicine
Research
Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trial

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 201821135
Feb 201824203
Mar 201832335
Apr 201839373
May 201841393
Jun 201834241
Jul 201851313
Aug 201824142
Sep 201815133
Oct 201817173
Nov 201824243
Dec 201828242
Jan 201919152
Feb 201918144
Mar 201916125
Apr 201912116
May 20191574
Jun 2019862
Jul 201922166
Aug 20191772
Oct 201932146
Nov 201926186
Dec 20192773
Jan 202044292
Feb 202021154
Mar 2020662
May 2020774
Jun 2020181610
Jul 202028225
Aug 202024196
Sep 202016162
Oct 202030305
Nov 202019189
Dec 202029297
Jan 202131307
Feb 202118184
Mar 202122204
Apr 202130312
May 202142426
Jun 202129295
Jul 202123234
Aug 202123237
Sep 202141418
Oct 2021262416
Nov 2021393716
Dec 202134343
Jan 202227274
Feb 202228261
Mar 202251543
Apr 202227245
May 2022202112
Jun 202222229
Jul 202225263
Aug 202224206
Sep 2022232310
Oct 202227276
Nov 202211113
Dec 202219182
Jan 202322216
Feb 202318160
Mar 2023222111
Apr 202324225
May 202318911
Jun 202317156
Jul 2023667
Aug 202316127
Sep 2023771
Oct 202320200
Nov 202316188
Dec 202326269
Jan 202430295
Feb 2024431
Mar 202410743
Apr 20247630
Total17291512434